WHO says new China virus could spread, it’s warning all hospitals
There has been “limited” human-to-human transmission of a new coronavirus that has struck in China, mainly small clusters in families, but there is potential for...
Ryanair says could start getting Boeing 737 MAX by April
Ryanair could receive its first deliveries of up to 10 grounded 737 MAX aircraft from Boeing by April, Chief Marketing Officer Kenny Jacobs said on...
Irish PM to call Feb. 8 national election: reports
Irish Prime Minister Leo Varadkar will ask President Michael D. Higgins to dissolve parliament on Tuesday in order to call a parliamentary election on Feb....
UK’s PM proposes crowdfunding to allow Big Ben to bong for Brexit
British Prime Minister Boris Johnson on Tuesday proposed a crowdfunding campaign to allow Big Ben bell in parliament’s landmark clock tower to ring out when...
Ryanair says could see first Boeing 737 MAX deliveries in April
Ryanair could receive its first deliveries of up to 10 grounded 737 MAX aircraft from Boeing by April, Chief Marketing Officer Kenny Jacobs said on...
Lyft forms advisory council to improve platform safety
Lyft Inc is putting together a council of experts to advise the ride-hailing company on its safety initiatives for riders and drivers, it said in...
Nokia lowers cost cut target to invest in 5G and digitalization
The Finnish telecoms equipment maker Nokia lowered its cost savings target to 500 million euros ($557 million) from the previous 700 million by the end...
BlackRock takes tougher stance on climate after activist heat
BlackRock Chief Executive Larry Fink has warned company boards to step up efforts to tackle climate change, marking a significant shift in the public stance...
Billionaire Maezawa tops Japan’s most followed Twitter rankings
Fashion billionaire Yusaku Maezawa has became Japan’s most followed Twitter account, the social network said, boosted by a $9 million giveaway to his followers....
Roche aims to ‘underwhelm’ on SMA drug price to challenge rivals
Swiss drugmaker Roche plans to price its oral spinal muscular atrophy drug (SMA) risdiplam aggressively to challenge two of the world’s most expensive medicines, Biogen’s...